BioNTech SE (BNTX) Other Non Operating Income (2020 - 2025)
BioNTech SE's (BNTX) quarterly Other Non Operating Income came in at -$452783.9 in Q2 2025, up 83.18% year-on-year from -$247177.4 in Q2 2024, and up 98.34% quarter-over-quarter from -$27.3 million in Q1 2025.
BioNTech SE (BNTX) Other Non Operating Income (2020 - 2025) Analysis & Trends
BioNTech SE has disclosed Other Non Operating Income across 6 years of filings, most recently posting -$452783.9 for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -452,783.88 |
| Mar 31, 2025 | -27.35 Mn |
| Sep 30, 2024 | -13.18 Mn |
| Jun 30, 2024 | -2.69 Mn |
| Mar 31, 2024 | 5.65 Mn |
| Sep 30, 2023 | 4.25 Mn |
| Jun 30, 2023 | 28.09 Mn |
| Mar 31, 2023 | -29.84 Mn |
| Sep 30, 2022 | 27.43 Mn |
| Sep 30, 2021 | 30.66 Mn |
| Sep 30, 2020 | -16.35 Mn |